⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 25, 2024Reviews in Cardiovascular MedicineOpen Access

Association between the C-Reactive Protein–Albumin–Lymphocyte (CALLY) Index and Adverse Clinical Outcomes in CAD Patients after PCI: Findings of a Real-World Study

Ying Pan Tingting Wu Chang‐Jiang Deng Zhi-Hui Jiang Yi Yang Xian‐Geng Hou Tuo Yan Shun Wang Yu-Juan Feng Ying‐Ying Zheng Xiang Xie

View Full Paper

Ask AI

Bookmark

Share

Abstract

The C-reactive protein-albumin-lymphocyte (CALLY) index is a novel inflammatory biomarker, and its association with the prognosis of coronary artery disease (CAD) after percutaneous coronary intervention (PCI) has not previously been studied. Therefore, this study aimed to investigate the effect of using the CALLY index on adverse outcomes in CAD patients undergoing PCI.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pan et al. (2024) studied this question.

synapsesocial.com/papers/68e72652b6db6435876a0627 https://doi.org/10.31083/j.rcm2504111

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A novel indicator of all-cause mortality in acute coronary syndrome: the CALLY indexcohort · 2025 · 19 citations
2C-Reactive Protein-Albumin-Lymphocyte Index (Cally) As A Prognostic Biomarker in Colorectal Cancer: A Systematic Review2025
3The C-reactive protein–albumin–lymphocyte index is associated with coronary collateral circulation in patients with chronic total occlusioncross-sectional · 2026
4Prognostic usefulness of the C-reactive protein-albumin-lymphocyte (CALLY) index as a novel biomarker in patients undergoing colorectal cancer surgery2024 · 65 citations
5The C-reactive protein–albumin–lymphocyte index is associated with ventricular functional improvement and long-term outcomes after cardiac resynchronization therapycohort · 2026